USD
$0.00
(0.00%
)At Close (As of Sep 9, 2025)
$7.24M
Market Cap
-
P/E Ratio
-0.57
EPS
$2.25
52 Week High
$0.16
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $3.4M |
Total Revenue | $9.4M |
Cost Of Revenue | $6M |
Costof Goods And Services Sold | $6M |
Operating Income | -$9M |
Selling General And Administrative | $9.9M |
Research And Development | $1.8M |
Operating Expenses | $12M |
Investment Income Net | - |
Net Interest Income | -$75K |
Interest Income | $18K |
Interest Expense | $92K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $606K |
Income Before Tax | -$9M |
Income Tax Expense | $12K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$9M |
Comprehensive Income Net Of Tax | - |
Ebit | -$8.9M |
Ebitda | -$8.3M |
Net Income | -$9M |
Field | Value (USD) |
---|---|
Total Assets | $6.5M |
Total Current Assets | $2.7M |
Cash And Cash Equivalents At Carrying Value | $1.1M |
Cash And Short Term Investments | $1.1M |
Inventory | $28K |
Current Net Receivables | $1.1M |
Total Non Current Assets | $3.8M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $775K |
Intangible Assets Excluding Goodwill | $775K |
Goodwill | $1.4M |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $423K |
Other Non Current Assets | - |
Total Liabilities | $3.9M |
Total Current Liabilities | $3.1M |
Current Accounts Payable | $987K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.2M |
Total Non Current Liabilities | $807K |
Capital Lease Obligations | $1.3M |
Long Term Debt | $20K |
Current Long Term Debt | $172K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.5M |
Other Current Liabilities | $876K |
Other Non Current Liabilities | - |
Total Shareholder Equity | $2.6M |
Treasury Stock | - |
Retained Earnings | -$54M |
Common Stock | $107K |
Common Stock Shares Outstanding | $12M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$7.3M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $606K |
Capital Expenditures | $79K |
Change In Receivables | - |
Change In Inventory | -$9.1K |
Profit Loss | - |
Cashflow From Investment | -$79K |
Cashflow From Financing | $5.6M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$9M |
Field | Value (USD) |
---|---|
Gross Profit | $3.4M |
Total Revenue | $9.4M |
Cost Of Revenue | $6M |
Costof Goods And Services Sold | $6M |
Operating Income | -$9M |
Selling General And Administrative | $9.9M |
Research And Development | $1.8M |
Operating Expenses | $12M |
Investment Income Net | - |
Net Interest Income | -$75K |
Interest Income | $18K |
Interest Expense | $92K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $606K |
Income Before Tax | -$9M |
Income Tax Expense | $12K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$9M |
Comprehensive Income Net Of Tax | - |
Ebit | -$8.9M |
Ebitda | -$8.3M |
Net Income | -$9M |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer. The company is headquartered in San Antonio, Texas.